In the past, we encountered challenges that seemed beyond reach. However, as science advances, we realize that the impossible is being redefined. Could permanent injuries be reversed? Could surgeons operate without ever touching the patient? Could the mind merge seamlessly with technology?
In the Symbiotic Evolution: The Rise of Human-Machine Integration module, we will explore the latest innovations in biomedical engineering, led by the visionaries shaping the future of medicine.
Pieter Roelfsema is a leading neuroscientist specialising in visual perception, neural coding, and brain-machine interfaces. As Director of the Netherlands Institute for Neuroscience and Professor at Vrije Universiteit Amsterdam, he has advanced the understanding of how the brain processes visual information and attention. His research focuses on perception, learning, and plasticity, using neuro-imaging, electrophysiology, and computational modelling. Roelfsema is renowned for developing brain-computer interfaces to restore vision in the blind. Through his leadership, he promotes interdisciplinary work to address brain function and treat neurological and psychiatric disorders, making him a key figure in neuroscience.
Nicolas Simon is a pioneering engineer and entrepreneur in robotics and human-machine interfaces. As co-founder and CEO of Wandercraft, he has led the development of advanced, self-balancing exoskeletons that restore mobility to individuals with lower-limb disabilities. These AI-powered devices replicate natural gait, allowing users to walk without crutches—a major breakthrough in rehabilitation robotics. Simon’s work enhances autonomy and quality of life for people with mobility challenges. Under his leadership, Wandercraft collaborates across biomechanics, neuroscience, and healthcare, positioning him at the forefront of innovation in assistive technology and human-machine integration.
Rafal Nowak is a neuroscientist and innovator specialising in neuroimaging, electrophysiology, and neuroscience. He has pioneered methods using EEG and MEG to identify neurological biomarkers and assess interventions. His work was the first to show the feasibility of simultaneous intracranial EEG and MEG recordings, enhancing the localisation of deep brain signals and detection of epileptogenic zones. Dr. Nowak has contributed significantly to auditory neuroscience, MEG signal processing, and home-based neurostimulation, particularly in tDCS. As head of business development at Neuroelectrics, he advances neurotechnology by integrating AI and machine learning into biomarker discovery. He is also a Global Atlantic Fellow for Equity in Brain Health, supporting international brain health initiatives.